Self-assembled nano-capture antibacterial peptide KIL4 as well as preparation method and application thereof
By designing and assembling self-contained nanoparticles to capture the antimicrobial peptide KIL4, the issues of biotoxicity and environmental sensitivity of antimicrobial peptides in clinical applications have been resolved. This has enabled the effective inhibition and capture of Gram-positive and Gram-negative bacteria, providing technical support for novel antimicrobial drugs.
Patent Information
- Application Number
- CN202511526587.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-24
- Publication Date
- 2026-02-06
AI Technical Summary
Existing antimicrobial peptides face issues of biotoxicity and environmental sensitivity in clinical applications, making it difficult to fully realize their antimicrobial efficacy.
A self-assembled nanoparticle-capturing antimicrobial peptide, KIL4, was designed. By forming a nanostructure through specific amino acid sequences and self-assembly conditions, its stability and targeted binding ability were enhanced. It was prepared and purified by solid-phase chemical synthesis, and its nanomorphology and biocompatibility were tested.
It achieves significant inhibition of both Gram-positive and Gram-negative bacteria, exhibits good biocompatibility and bacterial capture ability, and provides technical support for novel antibacterial drugs.